BLT 0.00% 2.6¢ benitec biopharma limited

Ann: BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX, page-12

  1. 364 Posts.
    lightbulb Created with Sketch. 135
    I'm no medical expert or scientist, I'm bordering on one of the worst investors/ traders of all time, but as I understand it primary end point of safety was met and as tt-034 trial being stopped, doesn't all this wonderful data mean we have set HBV trial up for dosages etc. meaning we won't have to wait the long period we did with tt-034 trial?

    BLT owes me close to 6 figures, but I'm not out until I get my 7 figure pay day.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.